Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
Crossref DOI link: https://doi.org/10.1007/s40261-015-0372-9
Published Online: 2015-12-30
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hasvold, Pål
Thuresson, Marcus
Sundström, Johan
Hammar, Niklas
Kjeldsen, Sverre E.
Johansson, Gunnar
Holme, Ingar
Bodegård, Johan
Funding for this research was provided by:
AstraZeneca Nordic
License valid from 2015-12-30